SCHEMBL6548377

SCHEMBL6548377

O=Cc1cccc(OCCCOc2c(Cl)cc(OCC=C(Cl)Cl)cc2Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 0.41
MAOB P27338 7/20 0.41
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ORAI1 Q96D31 1/20 0.38
FURIN P09958 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SRC P12931 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYSLTR2 Q9NS75 3/20 0.35
CYSLTR1 Q9Y271 3/20 0.35
TLR4 O00206 1/20 0.34
TLR2 O60603 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6548549 0.98 MAOA (0.41) MAOAMAOBNPC1RAB9AGAA
SCHEMBL5605592 0.87 ALDH1A1 (0.45) RAB9AMAPTHPGDKMT2ASMN1; SMN2
SCHEMBL6548689 0.86 FURIN (0.44) NPC1RAB9AMAPTHPGDKMT2A
SCHEMBL6548692 0.86 FURIN (0.44) NPC1RAB9AMAPTHPGDKMT2A
SCHEMBL8658605 0.85 PPARG (0.44) MAOBKMT2ASMN1; SMN2HTT
SCHEMBL4522495 0.85 MAOA (0.54) MAOAMAOBNPC1RAB9AGAA
SCHEMBL6547674 0.84 ALDH1A1 (0.42) RAB9AMAPTHPGDKMT2ASMN1; SMN2
SCHEMBL8408702 0.84 KCNA3 (0.41) NPC1RAB9AMAPTHPGDHTT
SCHEMBL6548537 0.84 FURIN (0.42) NPC1RAB9AMAPTHPGDKMT2A
SCHEMBL6548542 0.84 FURIN (0.42) NPC1RAB9AMAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0975586-B1 OXIME COMPOUNDS, THEIR USE, AND INTERMEDIATES FOR THEIR PRODUCTION SUMITOMO CHEMICAL CO (JP) 2004-12-01 EP disclosed
US-6448444-B2 INSECTICIDES, MITICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-09-10 US disclosed
US-6437184-B1 INSECTICIDES, ACARICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-08-20 US disclosed
US-20020019569-A1 Oxime compounds, their use, and intermediates for their production SUMITOMO CHEMICAL COMPANY, LIMITED 2002-02-14 US disclosed
EP-0975586-A2 OXIME COMPOUNDS, THEIR USE, AND INTERMEDIATES FOR THEIR PRODUCTION Sumitomo Chemical Company, Limited (JP) 2000-02-02 EP disclosed
WO-1998045254-A2 OXIME COMPOUNDS, THEIR USE, AND INTERMEDIATES FOR THEIR PRODUCTION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019569-A1 Oxime compounds, their use, and intermediates for their production CBR3, CBR1, NOX3 MAOA 944/4885MAOB 1041/4885NPC1 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.